Emil F Coccaro1, Royce Lee1, Mary Coussons-Read2. 1. Clinical Neuroscience Research Unit, Department of Psychiatry and Behavioral Neuroscience, Pritzker School of Medicine, University of Chicago, Chicago, Illinois. 2. Department of Psychology, University of Colorado Colorado Springs, Colorado Springs.
Abstract
IMPORTANCE: Neurochemical studies in human aggression point to a modulatory role for a variety of central neurotransmitters. Some of these neurotransmitters play an inhibitory role, while others play a facilitatory role modulating aggression. Preclinical studies suggest a facilitatory role for inflammatory markers in aggression. Despite this, to our knowledge, no studies of aggression and inflammatory markers have been reported in psychiatric patients or in individuals with recurrent, problematic, impulsive aggressive behavior. OBJECTIVE: To test the hypothesis that plasma inflammatory markers will correlate directly with aggression and will be elevated in individuals with recurrent, problematic, impulsive aggressive behavior. DESIGN, SETTING, AND PARTICIPANTS Case-control study in a clinical research program in impulsive aggressive behavior at an academic medical center. Participants were physically healthy individuals with intermittent explosive disorder (n = 69), nonaggressive individuals with Axis I and/or II disorders (n = 61), and nonaggressive individuals without history of an Axis I or II disorder (n = 67). MAIN OUTCOMES AND MEASURES: Plasma levels of C-reactive protein and interleukin 6 were examined in the context of measures of aggression and impulsivity and as a function of intermittent explosive disorder. RESULTS: Both plasma C-reactive protein and interleukin 6 levels were significantly higher in participants with intermittent explosive disorder compared with psychiatric or normal controls. In addition, both inflammatory markers were directly correlated with a composite measure of aggression and, more specifically, with measures reflecting history of actual aggressive behavior in all participants. CONCLUSIONS AND RELEVANCE: These data suggest a direct relationship between plasma inflammatory processes and aggression in humans. This finding adds to the complex picture of the central neuromodulatory role of aggression in humans.
IMPORTANCE: Neurochemical studies in humanaggression point to a modulatory role for a variety of central neurotransmitters. Some of these neurotransmitters play an inhibitory role, while others play a facilitatory role modulating aggression. Preclinical studies suggest a facilitatory role for inflammatory markers in aggression. Despite this, to our knowledge, no studies of aggression and inflammatory markers have been reported in psychiatricpatients or in individuals with recurrent, problematic, impulsive aggressive behavior. OBJECTIVE: To test the hypothesis that plasma inflammatory markers will correlate directly with aggression and will be elevated in individuals with recurrent, problematic, impulsive aggressive behavior. DESIGN, SETTING, AND PARTICIPANTS Case-control study in a clinical research program in impulsive aggressive behavior at an academic medical center. Participants were physically healthy individuals with intermittent explosive disorder (n = 69), nonaggressive individuals with Axis I and/or II disorders (n = 61), and nonaggressive individuals without history of an Axis I or II disorder (n = 67). MAIN OUTCOMES AND MEASURES: Plasma levels of C-reactive protein and interleukin 6 were examined in the context of measures of aggression and impulsivity and as a function of intermittent explosive disorder. RESULTS: Both plasma C-reactive protein and interleukin 6 levels were significantly higher in participants with intermittent explosive disorder compared with psychiatric or normal controls. In addition, both inflammatory markers were directly correlated with a composite measure of aggression and, more specifically, with measures reflecting history of actual aggressive behavior in all participants. CONCLUSIONS AND RELEVANCE: These data suggest a direct relationship between plasma inflammatory processes and aggression in humans. This finding adds to the complex picture of the central neuromodulatory role of aggression in humans.
Authors: Martina Luchetti; James M Barkley; Yannick Stephan; Antonio Terracciano; Angelina R Sutin Journal: Psychoneuroendocrinology Date: 2014-09-02 Impact factor: 4.905
Authors: Karim Malki; Oliver Pain; Ebba Du Rietz; Maria Grazia Tosto; Jose Paya-Cano; Kenneth N Sandnabba; Sietse de Boer; Leonard C Schalkwyk; Frans Sluyter Journal: Neurogenetics Date: 2014-08-22 Impact factor: 2.660
Authors: Ashwin Jacob Mathai; Christopher A Lowry; Thomas B Cook; Lisa A Brenner; Lena Brundin; Maureen W Groer; Xiaoqing Peng; Ina Giegling; Annette M Hartmann; Bettina Konte; Marion Friedl; Dietmar Fuchs; Dan Rujescu; Teodor T Postolache Journal: Pteridines Date: 2016-10-21 Impact factor: 0.581
Authors: Nadine M Melhem; Sara Munroe; Anna Marsland; Katarina Gray; David Brent; Giovanna Porta; Antoine Douaihy; Mark L Laudenslager; Frank DePietro; Rasim Diler; Henry Driscoll; Priya Gopalan Journal: Psychoneuroendocrinology Date: 2017-01-10 Impact factor: 4.905
Authors: E E M Knowles; Joanne E Curran; Harald H H Göring; Samuel R Mathias; Josephine Mollon; Amanda Rodrigue; Rene L Olvera; Ana Leandro; Ravi Duggirala; Laura Almasy; John Blangero; David C Glahn Journal: Brain Behav Immun Date: 2019-04-03 Impact factor: 7.217
Authors: Royce Lee; Konstantinos Arfanakis; Arnold M Evia; Jennifer Fanning; Sarah Keedy; Emil F Coccaro Journal: Neuropsychopharmacology Date: 2016-05-20 Impact factor: 7.853
Authors: Emil F Coccaro; Royce Lee; Jennifer R Fanning; Dietmar Fuchs; Michel Goiny; Sophie Erhardt; Kyle Christensen; Lena Brundin; Mary Coussons-Read Journal: Psychoneuroendocrinology Date: 2016-05-06 Impact factor: 4.905